(0.31%) 5 116.00 points
(0.30%) 38 355 points
(0.37%) 15 986 points
(-0.98%) $83.03
(5.36%) $2.03
(0.34%) $2 355.10
(0.50%) $27.67
(4.17%) $960.55
(-0.27%) $0.932
(-0.44%) $10.98
(-0.57%) $0.796
(1.63%) $93.37
Live Chart Being Loaded With Signals
Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to sutures and secure the approximation of tissue through a flexible endoscope...
Stats | |
---|---|
本日の出来高 | 1.64M |
平均出来高 | 1.33M |
時価総額 | 579.72M |
EPS | $0 ( 2024-03-28 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -9.43 |
ATR14 | $0.0390 (0.39%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-04-04 | Mcgaughy R Kent Jr | Sell | 400 675 | Common Stock |
2023-04-04 | Mcgaughy R Kent Jr | Sell | 38 667 | Stock Option (Right to Buy) |
2023-04-04 | Cpmg Inc | Sell | 400 675 | Common Stock |
2023-04-04 | Barr John R | Sell | 44 082 | Common Stock |
2023-04-04 | Barr John R | Sell | 5 271 | Non-Qualified Stock Option (right to buy) |
INSIDER POWER |
---|
-16.28 |
Last 98 transactions |
Buy: 5 638 377 | Sell: 4 907 735 |
ボリューム 相関
Apollo Endosurgery Inc 相関
10 最も負の相関 | |
---|---|
BVXV | -0.948 |
SNPX | -0.938 |
SVAC | -0.935 |
FREQ | -0.934 |
PAIC | -0.933 |
SVOK | -0.928 |
TSP | -0.923 |
ALTM | -0.922 |
ZI | -0.919 |
SGRP | -0.917 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Apollo Endosurgery Inc 相関 - 通貨/商品
Apollo Endosurgery Inc 財務諸表
Annual | 2022 |
収益: | $76.86M |
総利益: | $42.43M (55.20 %) |
EPS: | $-0.980 |
FY | 2022 |
収益: | $76.86M |
総利益: | $42.43M (55.20 %) |
EPS: | $-0.980 |
FY | 2021 |
収益: | $62.99M |
総利益: | $34.96M (55.50 %) |
EPS: | $-0.820 |
FY | 2020 |
収益: | $42.05M |
総利益: | $22.24M (52.90 %) |
EPS: | $-0.990 |
Financial Reports:
No articles found.
Apollo Endosurgery Inc
Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, as well as delays gastric content emptying under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands. Additionally, the company offers X-Tack Endoscopic HeliX Tacking System, a suture-based device for closing and healing defects in the lower and upper gastrointestinal tract. The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Australia, Costa Rica, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。